Project Number ADDF-13 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator Ballard, Clive Principal Investigator First Name Clive Principal Investigator Last Name Ballard Awardee Organization UNIVERSITY OF EXETER Contact PI Country United Kingdom Project Detail FY Overall Cost $3,024,684 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
